Optimalisasi Kesadaran Kesehatan Metabolik melalui Pemeriksaan Profil Lipid di Kabupaten Lebak

Authors

  • Robert Kosasih Fakultas Kedokteran, Universitas Tarumanagara, Jakarta, Indonesia
  • Alexander Halim Santoso Fakultas Kedokteran Universitas Tarumanagara, Jakarta
  • Bryan Anna Wijaya Fakultas Kedokteran, Universitas Tarumanagara, Jakarta, Indonesia
  • Fidelia Alvianto Fakultas Kedokteran, Universitas Tarumanagara, Jakarta, Indonesia
  • Aditya Pratama Fakultas Kedokteran, Universitas Tarumanagara, Jakarta, Indonesia

DOI:

https://doi.org/10.69930/scitec.v2i4.615

Keywords:

Lebak, dislipidemia, kolesterol total, pemeriksaan komunitas, trigliserida

Abstract

Dislipidemia merupakan faktor risiko utama penyakit kardiovaskular yang masih menjadi penyebab morbiditas dan mortalitas tinggi secara global. Pemeriksaan profil lipid berbasis komunitas menjadi langkah strategis untuk deteksi dini dan edukasi kesehatan metabolik. Kegiatan ini bertujuan memperoleh gambaran status lipid masyarakat Kabupaten Lebak serta meningkatkan kesadaran terhadap pentingnya pencegahan penyakit kardiometabolik. Penelitian dilaksanakan pada 59 peserta dewasa menggunakan metode point-of-care testing (POCT) untuk menilai kadar kolesterol total, HDL, LDL, dan trigliserida. Hasil menunjukkan rerata kolesterol total 184,27 ± 32,78 mg/dL, trigliserida 186,42 ± 88,44 mg/dL, HDL 38,39 ± 11,67 mg/dL, dan LDL 110,5 ± 22,42 mg/dL. Sebanyak 35,6% responden berada pada kategori batas tinggi kolesterol total dan 40,7% memiliki kadar trigliserida di atas normal. Perempuan menunjukkan kadar kolesterol total, LDL, dan trigliserida lebih tinggi dibandingkan laki-laki, yang dapat dijelaskan oleh pengaruh hormonal, terutama penurunan estrogen pada fase perimenopause. Selain itu, kadar lipid cenderung meningkat pada usia >40 tahun akibat penurunan aktivitas enzim lipoprotein lipase dan reseptor LDL serta meningkatnya resistensi insulin. Temuan ini menegaskan pentingnya skrining profil lipid sebagai intervensi promotif–preventif untuk mendukung pengendalian faktor risiko metabolik di tingkat komunitas.

 

Downloads

Download data is not yet available.

References

Ali, N., Samadder, M., Kathak, R. R., & Islam, F. (2023). Prevalence and factors associated with dyslipidemia in Bangladeshi adults. PLOS ONE, 18(1), e0280672. https://doi.org/10.1371/journal.pone.0280672

Ballena-Caicedo, J., Zuzunaga-Montoya, F. E., Loayza-Castro, J. A., Vásquez-Romero, L. E. M., Tapia-Limonchi, R., De Carrillo, C. I. G., & Vera-Ponce, V. J. (2025). Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis. Journal of Health, Population and Nutrition, 44(1), 308. https://doi.org/10.1186/s41043-025-01054-3

Feng, L., Nian, S., Tong, Z., Zhu, Y., Li, Y., Zhang, C., Bai, X., Luo, X., Wu, M., & Yan, Z. (2020). Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population. BMJ Open, 10(3), e034226. https://doi.org/10.1136/bmjopen-2019-034226

Gebreegziabiher, G., Belachew, T., Mehari, K., & Tamiru, D. (2021). Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia. PLOS ONE, 16(2), e0243103. https://doi.org/10.1371/journal.pone.0243103

Giles, L. A. (2024). Hyperlipidemia Prevention and Management Utilizing Lifestyle Changes. Journal of Midwifery & Women’s Health, 69(3), 361–369. https://doi.org/10.1111/jmwh.13637

Hashempour, Z., Esmaeili, F., Tabatabaei-Malazy, O., Mosallanejad, A., & Panahi, G. (2025). Worldwide Prevalence of Dyslipidemia in Diabetes: An Umbrella Overview of the Meta-Analysis Studies. Endocrine, Metabolic & Immune Disorders - Drug Targets, 25. https://doi.org/10.2174/0118715303375795250521041740

Inaraja, V., Thuissard, I., Andreu-Vazquez, C., & Jodar, E. (2020). Lipid profile changes during the menopausal transition. Menopause, 27(7), 780–787. https://doi.org/10.1097/GME.0000000000001532

Islam, M. S., Wei, P., Suzauddula, M., Nime, I., Feroz, F., Acharjee, M., & Pan, F. (2024). The interplay of factors in metabolic syndrome: understanding its roots and complexity. Molecular Medicine, 30(1), 279. https://doi.org/10.1186/s10020-024-01019-y

Liang, J., Zhang, B., Hu, Y., Na, Z., & Li, D. (2023). Effects of steroid hormones on lipid metabolism in sexual dimorphism: A Mendelian randomization study. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.1119154

Lin, C.-F., Chang, Y.-H., Chien, S.-C., Lin, Y.-H., & Yeh, H.-Y. (2018). Epidemiology of Dyslipidemia in the Asia Pacific Region. International Journal of Gerontology, 12(1), 2–6. https://doi.org/10.1016/j.ijge.2018.02.010

Mahboob, M. (2024). Addressing the Public Health Crisis of Dyslipidemia. The Journal of Cardiovascular Diseases, 19(4). https://doi.org/10.55958/jcvd.v19i4.163

Manfredini, F., D’Addato, S., Laghi, L., Malagoni, A., Mandini, S., Boari, B., Borghi, C., & Manfredini, R. (2009). Influence of Lifestyle Measures on Hypertriglyceridaemia. Current Drug Targets, 10(4), 344–355. https://doi.org/10.2174/138945009787846407

Moreno, S., Ayers, C., Nguyen, N., Rohatgi, A., & Lau, E. S. (2024). Lipid changes across menopause status point to increased cardiovascular risk. European Heart Journal, 45(Supplement_1). https://doi.org/10.1093/eurheartj/ehae666.2839

Palmisano, B. T., Zhu, L., Eckel, R. H., & Stafford, J. M. (2018). Sex differences in lipid and lipoprotein metabolism. Molecular Metabolism, 15, 45–55. https://doi.org/10.1016/j.molmet.2018.05.008

Pappan, N., Awosika, A. O., & Rehman, A. (2024). Dyslipidemia. In StatPearls [Internet]. StatPearls Publishing.

Purnomo, Y. A., Santoso, A. H., Gunaidi, F. C., Setiawan, F. V., & Wijaya, B. A. (2025). Available online at : https://jurnal.stikeskesosi.ac.id/index.php/CompromiseJournal. Ldl.

Rozing, M. P., & Westendorp, R. G. J. (2023). Altered cardiovascular risk pattern of LDL cholesterol in older adults. Current Opinion in Lipidology, 34(1), 22–26. https://doi.org/10.1097/MOL.0000000000000859

Sarkar, S., Prasanna, V. S., Das, P., Suzuki, H., Fujihara, K., Kodama, S., Sone, H., Sreedhar, R., Velayutham, R., Watanabe, K., & Arumugam, S. (2024). The onset and the development of cardiometabolic aging: an insight into the underlying mechanisms. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1447890

Shabana, Shahid, S. U., & Sarwar, S. (2020). The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects. Lipids in Health and Disease, 19(1), 73. https://doi.org/10.1186/s12944-020-01248-0

Shi, M., Wang, H., & Zhang, X. (2024). Dyslipidemia and its associated factors among community adults located in Shangcheng district, Zhejiang province. Scientific Reports, 14(1), 4268. https://doi.org/10.1038/s41598-024-54953-6

Song, R., Hu, M., Qin, X., Qiu, L., Wang, P., Zhang, X., Liu, R., & Wang, X. (2023). The Roles of Lipid Metabolism in the Pathogenesis of Chronic Diseases in the Elderly. Nutrients, 15(15), 3433. https://doi.org/10.3390/nu15153433

Varlamov, O., Bethea, C. L., & Roberts, C. T. (2015). Sex-Specific Differences in Lipid and Glucose Metabolism. Frontiers in Endocrinology, 5. https://doi.org/10.3389/fendo.2014.00241

Downloads

Published

2025-12-30

How to Cite

Kosasih, R., Santoso, A. H., Wijaya, B. A., Alvianto, F., & Pratama, A. (2025). Optimalisasi Kesadaran Kesehatan Metabolik melalui Pemeriksaan Profil Lipid di Kabupaten Lebak. Science and Technology: Jurnal Pengabdian Masyarakat , 2(4), 407–417. https://doi.org/10.69930/scitec.v2i4.615

Issue

Section

Articles

Most read articles by the same author(s)

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.